Regional Chemotherapy of the Lung: Transpulmonary Chemoembolization in Malignant Lung Tumors

 

 Buy Article Permissions and Reprints

Abstract

Standard treatment options in patients with lung cancer and pulmonary metastases are surgery, radiotherapy, chemotherapy, and immunotherapy. For reducing clinical complications of surgery and achieving a better local response, transpulmonary chemoembolization of the lungs is a possible interventional technique in which anticancer drugs are administered directly into a tumor through its feeding vessels followed by occlusive agents that are injected through the delivery catheter for blocking the vessel. This allows a longer contact period in the tumor with a higher cytostatic drug concentration. The technique is safe and results present promising local response rates, but the influence on survival is still questionable. This article describes the current role of intravascular therapies in the treatment of pulmonary malignancies.

• References

• 1 Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55 (2) 74-108
  Google Scholar
• 2 Thun MJ, Henley SJ, Calle EE. Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene 2002; 21 (48) 7307-7325
  CrossrefPubMedGoogle Scholar
• 3 Hughes JMB, Morrell NW. Pulmonary Circulation: From Basic Mechanisms to Clinical Practice. London, United Kingdom: Imperial College Press; 2001. :xix, 356
  CrossrefGoogle Scholar
• 4 Carden DL, Matthay MA, George RB. Chest Medicine: Essentials of Pulmonary and Critical Care Medicine. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005. :xvii, 652
  Google Scholar
• 5 Riquet M. Bronchial arteries and lymphatics of the lung. Thorac Surg Clin 2007; 17 (4) 619-638 , viii
  CrossrefPubMedGoogle Scholar
• 6 Schiller JH, Harrington D, Belani CP , et al; Eastern Cooperative Oncology Group. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346 (2) 92-98
  CrossrefPubMedGoogle Scholar
• 7 Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer 2006; 6 (8) 583-592
  CrossrefPubMedGoogle Scholar
• 8 Gonsalves CF, Brown DB. Chemoembolization of hepatic malignancy. Abdom Imaging 2009; 34 (5) 557-565
  CrossrefPubMedGoogle Scholar
• 9 Golder WA. Chemoembolization of the lungs: basic anatomical elements, experimental results, clinical experience. Onkologe 2008; 14: 934-939
  CrossrefPubMedGoogle Scholar
• 10 Lindemayr S, Lehnert T, Korkusuz H, Hammerstingl R, Vogl TJ. Transpulmonary chemoembolization: a novel approach for the treatment of unresectable lung tumors. Tech Vasc Interv Radiol 2007; 10 (2) 114-119
  CrossrefPubMedGoogle Scholar
• 11 Lewis AL, Gonzalez MV, Lloyd AW , et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 2006; 17 (2 Pt 1) 335-342
  CrossrefPubMedGoogle Scholar
• 12 Vogl TJ, Wetter A, Lindemayr S, Zangos S. Treatment of unresectable lung metastases with transpulmonary chemoembolization: preliminary experience. Radiology 2005; 234 (3) 917-922
  CrossrefPubMedGoogle Scholar
• 13 Jiang GM, Zhao JW, Chen YX, Tian F. Blood supply of pulmonary metastases and its clinical significance [in Chinese]. Ai Zheng 2006; 25 (7) 885-887
  PubMedGoogle Scholar
• 14 Kahn PC, Paul RE, Rheinlander HF. Selective bronchial arteriography and intra-arterial chemotherapy in carcinoma of the lung. J Thorac Cardiovasc Surg 1965; 50 (5) 640-645
  PubMedGoogle Scholar
• 15 Hellekant C, Jonsson K. Double blood supply of bronchogenic carcinoma from multiple arteries. Acta Radiol Diagn (Stockh) 1981; 22 (4) 403-406
  PubMedGoogle Scholar
• 16 Nakanishi M, Umeda Y, Demura Y , et al. Effective use of multi-arterial infusion chemotherapy for advanced non-small cell lung cancer patients: four clinical specified cases. Lung Cancer 2007; 55 (2) 241-247
  CrossrefPubMedGoogle Scholar
• 17 Nakanishi M, Demura Y, Umeda Y , et al. Multi-arterial infusion chemotherapy for non-small cell lung carcinoma—significance of detecting feeding arteries and tumor staining. Lung Cancer 2008; 61 (2) 227-234
  CrossrefPubMedGoogle Scholar
• 18 Mallick R, Demmy T. Regional lung chemotherapy techniques. Innovations (Phila) 2011; 6 (1) 1-9
  PubMedGoogle Scholar
• 19 Urano M, Kuroda M, Nishimura Y. For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 1999; 15 (2) 79-107
  CrossrefPubMedGoogle Scholar
• 20 Demmy TL, Tomaszewski G, Dy GK , et al. Thoracoscopic organ suffusion for regional lung chemotherapy (preliminary results). Ann Thorac Surg 2009; 88 (2) 385-390 ; discussion 390–391
  CrossrefPubMedGoogle Scholar
• 21 Carpenter AJ, Follette DM, Sheppard B, Yoshikawa R, Sam J. Simultaneous antegrade and retrograde reperfusion after cardioplegic arrest for coronary artery bypass. J Card Surg 1999; 14 (5) 354-358
  CrossrefPubMedGoogle Scholar
• 22 Vogt-Moykopf I, Bulzebruck H, Kryza S, Kruschinski H, Branscheid D, Schirren J. Results in surgery of pulmonary metastases. Chirurgie 1992; 118 (5) 263-271
  PubMedGoogle Scholar
• 23 Friedel G, Pastorino U, Buyse M , et al. [Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases—the International Registry of Lung Metastases [in German]. Zentralbl Chir 1999; 124 (2) 96-103
  PubMedGoogle Scholar
• 24 Hendriks JM, Romijn S, Van Putte B , et al. Long-term results of surgical resection of lung metastases. Acta Chir Belg 2001; 101 (6) 267-272
  PubMedGoogle Scholar
• 25 Abecasis N, Cortez F, Bettencourt A, Costa CS, Orvalho F, de Almeida JM. Surgical treatment of lung metastases: prognostic factors for long-term survival. J Surg Oncol 1999; 72 (4) 193-198
  CrossrefPubMedGoogle Scholar
• 26 Lanza LA, Putnam Jr JB, Benjamin RS, Roth JA. Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases. Ann Thorac Surg 1991; 51 (2) 219-224
  CrossrefPubMedGoogle Scholar
• 27 Casson AG, Putnam JB, Natarajan G , et al. Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer 1992; 69 (3) 662-668
  CrossrefPubMedGoogle Scholar
• 28 Ueda T, Uchida A, Kodama K , et al. Aggressive pulmonary metastasectomy for soft tissue sarcomas. Cancer 1993; 72 (6) 1919-1925
  CrossrefPubMedGoogle Scholar
• 29 Weksler B, Ng B, Lenert JT, Burt ME. Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection. Ann Thorac Surg 1993; 56 (2) 209-214
  CrossrefPubMedGoogle Scholar
• 30 Mountain CF, Khalil KG, Hermes KE, Frazier OH. The contribution of surgery to the management of carcinomatous pulmonary metastases. Cancer 1978; 41 (3) 833-840
  CrossrefPubMedGoogle Scholar
• 31 Inoue Y, Miki C, Hiro J , et al. Improved survival using multi-modality therapy in patients with lung metastases from colorectal cancer: a preliminary study. Oncol Rep 2005; 14 (6) 1571-1576
  PubMedGoogle Scholar
• 32 Van Putte BP, Hendriks JM, Romijn S , et al. Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model. Ann Thorac Surg 2002; 74 (3) 893-898 ; discussion 898
  CrossrefPubMedGoogle Scholar
• 33 Romijn S, Hendriks JM, Van Putte BP , et al. Regional differences of melphalan lung levels after isolated lung perfusion in the rat. J Surg Res 2005; 125 (2) 157-160
  CrossrefPubMedGoogle Scholar
• 34 Schneider P, Kampfer S, Loddenkemper C, Foitzik T, Buhr HJ. Chemoembolization of the lung improves tumor control in a rat model. Clin Cancer Res 2002; 8 (7) 2463-2468
  PubMedGoogle Scholar
• 35 Wagner W, von Eiff M, Klinke F, Micke O, Rübe C, Willich N. [Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study [in German]. Strahlenther Onkol 1995; 171 (7) 390-397
  PubMedGoogle Scholar
• 36 Lindemayr S, Lehnert T, Korkusuz H, Hammerstingl R, Vogl TJ. Transpulmonary chemoembolization: a novel approach for the treatment of unresectable lung tumors. Tech Vasc Interv Radiol 2007; 10 (2) 114-119
  CrossrefPubMedGoogle Scholar
• 37 Watanabe Y, Shimizu J, Murakami S , et al. Reappraisal of bronchial arterial infusion therapy for advanced lung cancer. Jpn J Surg 1990; 20 (1) 27-35
  CrossrefPubMedGoogle Scholar
• 38 Shi W, Zhang S, Zhang X. Treatment of non-small-cell lung cancer by dual (bronchial and pulmonary) arterial drug infusion [in Chinese]. Zhonghua Zhong Liu Za Zhi 1995; 17 (2) 146-148
  PubMedGoogle Scholar
• 39 Ratto GB, Toma S, Civalleri D , et al. Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg 1996; 112 (3) 614-622
  CrossrefPubMedGoogle Scholar
• 40 So T, Osaki T, Nakata S, Hanagiri T, Sugio K, Yasumoto K. Carinal resection after induction bronchial arterial infusion for locally advanced non-small cell lung cancer. Jpn J Thorac Cardiovasc Surg 2004; 52 (3) 143-147
  CrossrefPubMedGoogle Scholar
• 41 Schneider P, Foitzik T, Pohlen U, Golder W, Buhr HJ. Temporary unilateral microembolization of the lung—a new approach to regional chemotherapy for pulmonary metastases. J Surg Res 2002; 107 (2) 159-166
  CrossrefPubMedGoogle Scholar
• 42 Osaki T, Hanagiri T, Nakanishi R, Yoshino I, Taga S, Yasumoto K. Bronchial arterial infusion is an effective therapeutic modality for centrally located early-stage lung cancer: results of a pilot study. Chest 1999; 115 (5) 1424-1428
  CrossrefPubMedGoogle Scholar
• 43 Burt ME, Liu D, Abolhoda A , et al. Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial. Ann Thorac Surg 2000; 69 (5) 1542-1549
  CrossrefPubMedGoogle Scholar
• 44 Schröder C, Fisher S, Pieck AC , et al. Technique and results of hyperthermic (41 ° C) isolated lung perfusion with high-doses of cisplatin for the treatment of surgically relapsing or unresectable lung sarcoma metastasis. Eur J Cardiothorac Surg 2002; 22 (1) 41-46
  CrossrefPubMedGoogle Scholar
• 45 Karakousis CP, Park HC, Sharma SD, Kanter P. Regional chemotherapy via the pulmonary artery for pulmonary metastases. J Surg Oncol 1981; 18 (3) 249-255
  CrossrefPubMedGoogle Scholar
• 46 Liu CL, Wang YD, Jin XJ. Clinical observation on treatment of non-small cell lung cancer with Chinese herbal medicine combined with bronchial arterial infusion chemotherapy [in Chinese]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001; 21 (8) 579-581
  PubMedGoogle Scholar
• 47 Hendriks JM, Grootenboers MJ, Schramel FM , et al. Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial. Ann Thorac Surg 2004; 78 (6) 1919-1926 ; discussion 1926–1927
  CrossrefPubMedGoogle Scholar
• 48 Koshiishi H, Utsumi K, Tamamoto F, Takahashi E. Evaluation of bronchial arterial infusion (BAI) for high risk lung cancer [in Japanese]. Gan To Kagaku Ryoho 2000; 27 (12) 1907-1910
  PubMedGoogle Scholar
• 49 Johnston MR, Minchen RF, Dawson CA. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 1995; 110 (2) 368-373
  CrossrefPubMedGoogle Scholar
• 50 Pass HI, Mew DJ, Kranda KC, Temeck BK, Donington JS, Rosenberg SA. Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. Ann Thorac Surg 1996; 61 (6) 1609-1617
  CrossrefPubMedGoogle Scholar
• 51 Wang G, Song M, Xu H, Fang Y. Prospective trial of combined hyperfractionated radiotherapy and bronchial arterial infusion of chemotherapy for locally advanced nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1996; 34 (2) 309-313
  CrossrefPubMedGoogle Scholar